|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash and cash equivalents | ||||||
| Deferred offering costs | ||||||
| Prepaid expenses | ||||||
| Total Current Assets | ||||||
| Non-current asset | ||||||
| Cash held in Trust Account | ||||||
| Total non-current Asset | ||||||
| Total Assets | ||||||
| Current Liabilities | ||||||
| Accrued expenses | ||||||
| Promissory Note - related parties | ||||||
| Due to third parties | ||||||
| Due to related party | ||||||
| Total Current Liabilities | ||||||
| Commitments and Contingencies – (see Note 7) | ||||||
| Ordinary shares subject to possible redemption, 3,312,712 and 5,750,000 shares issued and outstanding at redemption value of $10.75 and $10.46 as of June 30, 2026 and March 31, 2026, respectively. | ||||||
| Shareholders’ Deficit | ||||||
| Preference shares, $0.0001 par value; 10,000,000 shares authorized; nil and nil shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively. | ||||||
| Ordinary shares, $0.0001 par value; 490,000,000 shares authorized; 1,908,348 and 1,908,348 shares issued and outstanding (excluding 3,312,712 shares subject to redemption) as of June 30, 2026 and March 31, 2026, respectively*. | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit |
Loading...
